The Ohio State University
Columbus, OH, United States
Brad H. Rovin, MD, FACP, FASN
Dr. Brad H. Rovin is the Lee A. Hebert Professor of Nephrology at the Ohio State University Wexner Medical Center. He is the Division Director of Nephrology and Medical Director of the Ohio State University Clinical Research Management Organization. Dr. Rovin conducts translational research on autoimmune glomerular diseases and applies these studies to clinical trial development and design for investigator-initiated and industry-sponsored trials of novel therapeutics.
Sunday, October 26, 2025
11:30 AM – 12:30 PM Central Time
Disclosure(s): Alexion: Consultant (Ongoing); Artiva: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); AstraZeneca: Consultant (Ongoing); Aurinia: Consultant (Ongoing), Grant/Research Support (Ongoing); Biogen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); cabaletta: Consultant (Ongoing); Century: Consultant (Ongoing); Genentech: Consultant (Ongoing); Novartis: Consultant (Ongoing); Roche: Consultant (Ongoing)
Sunday, October 26, 2025
4:00 PM – 5:00 PM Central Time
Disclosure(s): Alexion: Consultant (Ongoing); Artiva: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); AstraZeneca: Consultant (Ongoing); Aurinia: Consultant (Ongoing), Grant/Research Support (Ongoing); Biogen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); cabaletta: Consultant (Ongoing); Century: Consultant (Ongoing); Genentech: Consultant (Ongoing); Novartis: Consultant (Ongoing); Roche: Consultant (Ongoing)
